Home > Resources > Whitepapers > Origin Hybrid Pharmaceutical Packaging (HP3) Brochure

Origin Hybrid Pharmaceutical Packaging (HP3) Brochure

Origin’s ethos is everything we do, we innovate. Whether that is a new child resistant closure for a major pharmaceutical company, to a new, state of the art Enterprise Resource Planning System to further improve the customer’s experience with Origin and more importantly increasing speed to market. Passion fuels our drive to be thought leaders in primary packaging innovation, manufacturing and supply chain consolidation. We as a team have a passion for change, for making the world a better place. A passion to contribute, to make a difference. A passion to discover something new.

I'm For Real

Enter your details once to access all our information and resources

Spotlight

HealthCare Partners, A DaVita Medical Group

HealthCare Partners, a DaVita Medical Group is the country's largest operator of medical groups and physician networks, provides integrated care management as an operating division of DaVita, focusing on delivering outstanding healthcare across a broad range of services. HealthCare Partners works with its patients to help them live life to the fullest and strives to lead the transformation of the national healthcare delivery system to ensure quality, accessible and affordable care for all.

OTHER WHITEPAPERS
news image

Overcoming Pharma’s Launch Performance Problem

whitePaper | March 24, 2023

The prescription medicine market recovered from the wild swings of the early pandemic with renewed volume growth, driven by generics. COVID-19 vaccines and treatments have created a substantial market.

Read More
news image

National Council for Prescription Drug Programs

whitePaper | May 12, 2022

This document is Copyright © 2022 by the National Council for Prescription Drug Programs (NCPDP). It may be freely redistributed in its entirety provided this copyright notice is not removed.

Read More
news image

Access to medicinal products

whitePaper | January 3, 2022

There are many factors that can prevent a patient from being able to obtain the medicine they need, ranging from selective marketing decisions by companies to products being too expensive or pharmacy stock-outs

Read More
news image

Combatting Future Viral Threats with Vaccine Advances

whitePaper | February 3, 2023

Since the beginning of the COVID-19 pandemic, pharmaceutical organizations have experienced major changes, a prime example of which has been the rising requirement for collaborations on multiple different fronts across the industry.

Read More
news image

Pharma R&D Annual Review

whitePaper | March 15, 2022

Successes in 2021 – New active substance drug launches

Read More
news image

WILL PHARMA COMMIT TO DELIVERING AFFORDABLE THERAPEUTICS AGAINST COVID-19?

whitePaper | April 8, 2020

EPHA is a change agent – Europe’s leading NGO alliance advocating for better health. We are a dynamic member-led organisation, made up of public health civil society, patient groups, health professionals, and disease groups working together to improve health and strengthen the voice of public health in Europe.

Read More

Overcoming Pharma’s Launch Performance Problem

whitePaper | March 24, 2023

The prescription medicine market recovered from the wild swings of the early pandemic with renewed volume growth, driven by generics. COVID-19 vaccines and treatments have created a substantial market.

Read More

National Council for Prescription Drug Programs

whitePaper | May 12, 2022

This document is Copyright © 2022 by the National Council for Prescription Drug Programs (NCPDP). It may be freely redistributed in its entirety provided this copyright notice is not removed.

Read More

Access to medicinal products

whitePaper | January 3, 2022

There are many factors that can prevent a patient from being able to obtain the medicine they need, ranging from selective marketing decisions by companies to products being too expensive or pharmacy stock-outs

Read More

Combatting Future Viral Threats with Vaccine Advances

whitePaper | February 3, 2023

Since the beginning of the COVID-19 pandemic, pharmaceutical organizations have experienced major changes, a prime example of which has been the rising requirement for collaborations on multiple different fronts across the industry.

Read More

Pharma R&D Annual Review

whitePaper | March 15, 2022

Successes in 2021 – New active substance
drug launches

Read More

WILL PHARMA COMMIT TO DELIVERING AFFORDABLE THERAPEUTICS AGAINST COVID-19?

whitePaper | April 8, 2020

EPHA is a change agent – Europe’s leading NGO alliance advocating for better health. We are a dynamic member-led organisation, made up of public health civil society, patient groups, health professionals, and disease groups working together to improve health and strengthen the voice of public health in Europe.

Read More
More Whitepapers

Spotlight

HealthCare Partners, A DaVita Medical Group

HealthCare Partners, a DaVita Medical Group is the country's largest operator of medical groups and physician networks, provides integrated care management as an operating division of DaVita, focusing on delivering outstanding healthcare across a broad range of services. HealthCare Partners works with its patients to help them live life to the fullest and strives to lead the transformation of the national healthcare delivery system to ensure quality, accessible and affordable care for all.

Events

2024 AAPS NATIONAL BIOTECHNOLOGY CONFERENCE

Conference